Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2019 Jul 22;12(7):e229790. doi: 10.1136/bcr-2019-229790

Magnetic resonance features of sinonasal melanotic mucosal melanoma

Cosimo Nardi 1, Chiara Vignoli 1, Margherita Vannucchi 2, Michele Pietragalla 1
PMCID: PMC6663168  PMID: 31337627

Abstract

A 67-year-old man presented to ear, nose and throat department complaining of nasal congestion and recurrent epistaxis for 5 months. Nasal endoscopy revealed a pigmented polyp obstructing the right nasal cavity. MRI with contrast agent showed a right nasal cavity polypoid mass with hyper signal intensity (SI) both in non-enhanced T1-w and diffusion imaging, marked hypo SI in T2-w sequences and avidly contrast enhancement characterised by rapid wash-in without significant wash-out on dynamic perfusion imaging. Histological specimen showed epithelioid and spindle cells with focal intense pigmentations and immunohistochemical features compatible with primary melanotic sinonasal mucosal melanoma (SNM). As melanotic SNM shows MRI pathognomonic high non-enhanced T1-w SI, this case underlines the crucial role of MRI not only in assessing the local tumour extension/recurrence but also in increasing the diagnostic confidence of detecting melanotic SNM. Thus, MRI should be always performed in case of clinical–endoscopic suspicion of SNM.

Keywords: ear, nose and throat; nasal polyps; head and neck cancer; radiology

Background

Primary malignant sinonasal mucosal melanoma (SNM) is a rare and heavily aggressive sinonasal neoplasm. It represents <4% of all head and neck cancer, 55% of all head and neck melanoma and 0.3%–2% of all melanomas (annual incidence rate 0.5 per million).1 SNM mostly arises from melanocytes of the mucosa of the nasal cavity (50% of cases) and paranasal sinuses (20%).2–4 The average age of onset for SNM is 65 years (M:F 3:2).5 The etiopathogenetic is related to the cigarette smoking, formaldehyde and genetic alterations, whereas the solar exposure does not seem to play a key role.4 The primary sites of involvement are the nasal septum, the nasal lateral wall and the inferior nasal concha.1 It is necessary to exclude that the tumour is the secondary manifestation of cutaneous or uveal melanomas.2 Furthermore, symptoms are no specific (epistaxis, nasal obstruction and headache) and therefore the diagnosis is often delayed.6 MRI with contrast agent is the technique of choice in the study of monolateral sinonasal polypoid lesion since it distinguishes between solid lesions and inflammatory mucosal changes. As melanin has strongly hyperintense and hypointense signal intensity (SI) respect to the muscle in non-enhanced T1-w and T2-w sequences, respectively,3 MRI can be an important diagnostic tool in the diagnosis of melanotic SNM. MRI with diffusion-weighted imaging (DwI) and dynamic contrast enhancement imaging (DCE-PwI) can provide useful functional information in the characterisation of SNM. Moreover, MRI plays a basic role in the local–regional staging of malignant neoplasms with a higher diagnostic accuracy than CT in the assessment of dural, anterior skull base and orbit invasion.7 8

Case presentation

A 67-year-old patient presented to ear, nose and throat department complaining of nasal congestion and recurrent epistaxis for 5 months. Anticoagulant therapy, previous head and neck surgery, and history of tumour were not referred in anamnesis. The clinical examination showed a nasal profile deformation.

Investigations

Baseline biochemical and haematological investigations showed no abnormalities. The nasal endoscopy revealed a pigmented, ulcerated and friable polypoid mass that completely obstructed the right nasal cavity. MRI showed a mass occupying the right middle and inferior meatus characterised by hyper SI both in T1-w (figure 1) and DwI sequences (figure 2), and marked hypo SI in T2-w sequences. After intravenous contrast agent injection, the lesion showed marked enhancement with rapid wash-in and without significant wash-out on DCE-PwI time/intensity curve (figure 3). Therefore, an endoscopic biopsy was performed. Histological specimen of the lesion showed epithelioid and spindle cells with a focal and intense melanin pigmentation and immunohistochemical features compatible with primary sinonasal melanotic mucosal melanoma (figures 4 and 5).

Figure 1.

Figure 1

T1-w non-contrast enhanced coronal MRI. Polypoid lesion in the right nasal cavity with heterogeneous hyper signal intensity involves the inferior and middle meatus.

Figure 2.

Figure 2

Apparent diffusion coefficient (ADC) map shows a polypoid lesion in the right nasal cavity with low ADC values, a typical feature of SNM. Bilateral inflammatory mucosal changes with high ADC values are also present.

Figure 3.

Figure 3

Dynamic contrast enhancement perfusion-weighted imaging time–intensity curve shows a rapid wash-in without significant wash-out, a finding highly suspicious for malignancy.

Figure 4.

Figure 4

Histological specimen shows an aggregate of epithelioid and spindle cells with focal and intense pigmentation (magnification, 5x).

Figure 5.

Figure 5

Positivity for Melanoma-associated antigen recognized by T cells (MART-1) immunostaining (magnification, 20x).

Treatment

The patient underwent the surgical removal of the nasal mass and subsequent cycles of radiotherapy and chemotherapy.

Outcome and follow-up

In the staging phase, fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) and total body CT with contrast agent showed a pancreatic metastasis (figure 6). Early follow-up with total body CT showed both local and distant relapses of the disease. Metastases in the right temporal muscle (figure 7), bladder dome and lung appeared. Therefore, the immunological therapy was implemented. Nevertheless, the next CT scan revealed a further rapid progression of the disease with an increase of lung nodules and the appearance of liver metastases. The patient died after 3 months.

Figure 6.

Figure 6

18F-FDG positron emission tomography detects significant accumulation of the tracer in the nasal cavity (black arrow) and pancreatic head (black dotted arrow).

Figure 7.

Figure 7

Enhanced axial CT scan points out the massive local sinonasal recurrence and a metastasis in the right temporal muscle (white arrow).

Discussion

MRI plays a crucial role in the diagnosis, characterisation and local–regional staging of SNM. Therefore, MRI should be always performed if SNM is suspected from clinical–endoscopic examination. MRI features of SNM are variable, due to varying amounts of melanin, with up to one-third of cases being amelanotic.9 Melanin has strongly hyperintense SI respect to the muscle in non-enhanced T1-w and hypointense SI in T2-w sequences,3 thus melanotic SNM can be easily detected with MRI. On the contrary, amelanotic melanoma appears isointense to muscle in non-enhanced T1-w sequences.6 In SNM, DwI shows diffusion restriction with a high signal in images at high b-value (b800–1000) and low values in apparent diffusion coefficient (ADC) map, that prove the typical behaviour of malignant lesions (figure 2).10 DCE-PwI examines microvascular characteristics of tumour tissue giving information about benignity or malignancy. Malignant tumours are expected to have a rapid and vividly enhancement, despite benign lesions tend to have a progressive enhancing pattern.11 12 Tumour invasion of the orbits, base of the skull, intracranial and nasopharynx is common. T2-w sequences on the coronal plane allow to evaluate the erosion of the orbit inferior wall, lamina papyracea and ethmoidal cribriform plate, whereas isotropic–isovolumetric fat saturation sequences with contrast enhanced help to identify the infiltration of the dura mater and/or anterior cranial fossa.7 8 13 Cerebral oedema and leptomeningeal/cerebral impregnation in direct contact with the tumour are indicative of brain involvement.14 Distant metastases are common too.15 18F-FDG PET-CT scan FDG-PET/CT has been shown to be useful in evaluating residual or recurrent SNM.16 SNM is a very aggressive tumour with a poor prognosis with up to 64% recurrence 1 year after surgery17 and overall 5-year survival <25%.18 In conclusion, SNM is a rare entity and the nasal cavity is the most common site of origin. MRI can provide significant information in the diagnosis and local staging of SNM. High MRI SI on non-contrast enhanced T1-w and DwI sequences, low ADC values and rapid wash-in without noteworthy wash-out on DCE-PwI are very suggestive of melanotic SNM. PET-CT examination is mandatory for the assessment of distant metastasis.

Learning points.

  • MRI with contrast agent is the technique of choice in the study of monolateral sinonasal polypoid lesion since it distinguishes between solid lesions and inflammatory mucosal changes.

  • MRI plays a crucial role in the diagnosis and local–regional staging of sinonasal mucosal melanoma (SNM) and, therefore, it should be always performed in case of clinical–endoscopic suspicion.

  • Melanoma of the head and neck region is a rare entity and the nasal cavity is its most common site of origin. Melanotic SNM shows pathognomonic MRI features, especially a high signal intensity (SI) on non-contrast enhanced T1-w and diffusion-weighted imaging sequences, low SI on T2-w, and marked enhancement after intravenous contrast agent injection.

  • 18F-FDG positron emission tomography-CT examination is mandatory in patients with SNM both for diagnosis and follow-up to screen for distal metastases and local recurrences since they are common events and often associated with poor prognosis.

Footnotes

Contributors: CN: paper’s structure and review. CV: data collection. MV: histological images. MP: paper’s structure and review.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests: None declared.

Provenance and peer review: Not commissioned; externally peer reviewed.

Patient consent for publication: Obtained.

References

  • 1. Clifton N, Harrison L, Bradley PJ, et al. Malignant melanoma of nasal cavity and paranasal sinuses: report of 24 patients and literature review. J Laryngol Otol 2011;125:479–85. 10.1017/S0022215110002720 [DOI] [PubMed] [Google Scholar]
  • 2. Azoury SC, Epidemiology LJR, Factors R. Prevention, and Early Detection of Melanoma. Surg Clin North Am 2014;94:945–62. [DOI] [PubMed] [Google Scholar]
  • 3. Eggesbø HB. Imaging of sinonasal tumours. Cancer Imaging 2012;12:152 10.1102/1470-7330.2012.0015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Gilain L, Houette A, Montalban A, et al. Mucosal melanoma of the nasal cavity and paranasal sinuses. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131:365–9. 10.1016/j.anorl.2013.11.004 [DOI] [PubMed] [Google Scholar]
  • 5. Mochel MC, Duncan LM, Piris A, et al. Primary mucosal melanoma of the sinonasal tract: a clinicopathologic and immunohistochemical study of thirty-two cases. Head Neck Pathol 2015;9:236–43. 10.1007/s12105-014-0570-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Alves IS, Berriel LG, Alves RT, et al. Sinonasal Melanoma: A Case Report and Literature Review. Case Rep Oncol Med 2017;2017:1–6. 10.1155/2017/8201301 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Borges A, Coiteiro D, Santos JR, et al. Using magnetic resonance for the imaging of dural invasion by head and neck tumors. Imaging Med 2010;2:593–602. 10.2217/iim.10.51 [DOI] [Google Scholar]
  • 8. Turri-Zanoni M, Lambertoni A, Margherini S, et al. Multidisciplinary treatment algorithm for the management of sinonasal cancers with orbital invasion: A retrospective study. Head Neck 2019. 10.1002/hed.25759 [DOI] [PubMed] [Google Scholar]
  • 9. Nguyen B. Sinonasal malignant melanoma with diffuse metastasis: F-18 FDG PET/CT imaging. Radiology Case Reports 2008;03:3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Ascierto PA, Accorona R, Botti G, et al. Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol 2017;112:136–52. 10.1016/j.critrevonc.2017.01.019 [DOI] [PubMed] [Google Scholar]
  • 11. Bernstein JM, Homer JJ, West CM. Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic review. Oral Oncol 2014;50:963–70. 10.1016/j.oraloncology.2014.07.011 [DOI] [PubMed] [Google Scholar]
  • 12. Gaddikeri S, Gaddikeri RS, Tailor T, et al. Dynamic contrast-enhanced mr imaging in head and neck cancer: Techniques and clinical applications. AJNR Am J Neuroradiol 2016;37:1–8. 10.3174/ajnr.A4458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Iannetti G, Valentini V, Rinna C, et al. Ethmoido-orbital tumors: our experience. J Craniofac Surg 2005;16:1085–91. 10.1097/01.SCS.0000164332.81428.BA [DOI] [PubMed] [Google Scholar]
  • 14. Maroldi R, Ravanelli M, Borghesi A, et al. Paranasal sinus imaging. Eur J Radiol 2008;66:372–86. 10.1016/j.ejrad.2008.01.059 [DOI] [PubMed] [Google Scholar]
  • 15. O’Regan K, Breen M, Ramaiya N, et al. Metastatic mucosal melanoma: imaging patterns of metastasis and recurrence. Cancer Imaging 2013;13:626–32. 10.1102/1470-7330.2013.0055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Haerle SK, Soyka MB, Fischer DR, et al. The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma. Eur Arch Otorhinolaryngol 2012;269:127–33. 10.1007/s00405-011-1664-1 [DOI] [PubMed] [Google Scholar]
  • 17. Yoshioka H, Kamada T, Kandatsu S, et al. MRI of mucosal malignant melanoma of the head and neck. J Comput Assist Tomogr 1998;22:492–7. 10.1097/00004728-199805000-00024 [DOI] [PubMed] [Google Scholar]
  • 18. Gal TJ, Silver N, Huang B. Demographics and treatment trends in sinonasal mucosal melanoma. Laryngoscope 2011;121:n/a–2033. 10.1002/lary.21925 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES